What is the current market size?

The **Chromoendoscopy Agents market size** reached USD 1.2 billion in 2023, driven by rising demand for early disease detection and diagnostic accuracy.

What is the expected growth rate?

The market is projected to grow at a **CAGR of 5.5%** from 2026 to 2033, fueled by advancements in endoscopic imaging technologies.

What are the key growth drivers?

Key drivers include increasing prevalence of gastrointestinal disorders, adoption of minimally invasive procedures, and rising healthcare expenditure in emerging economies.

What challenges does the market face?

High costs of advanced agents and limited reimbursement policies hinder growth, particularly in low-income regions.

Which regions lead the market?

North America dominates due to technological adoption, while Asia-Pacific shows rapid growth from expanding healthcare infrastructure.

Who are the top companies?

Leading firms include Olympus, Fujifilm, and Pentax, known for innovation in endoscopic imaging and strategic partnerships.

What future opportunities exist?

Emerging opportunities lie in AI-integrated solutions, personalized medicine, and expanding applications beyond gastrointestinal diagnostics.

How does technology impact the market?

Technological advancements like AI-driven image analysis enhance diagnostic precision, accelerating market growth and adoption.

What is the regulatory landscape?

Regulatory bodies like FDA and EMA focus on safety and efficacy, with evolving guidelines shaping product approvals and market entry strategies.

Chromoendoscopy Agents Market Intelligence Report 2026 — Updated June 2026

Chromoendoscopy Agents by Application (Hospitals, Clinics, Others), by Types (Methylene Blue, Toluidine Blue, Acetic Acid, Indigo Carmine), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 99

Forecast Period: 2026 - 2033

Market Size: $95 million

CAGR: 3.1%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Pages: 99

Forecast Period: 2026 - 2033

Market Size: $95 million

CAGR: 3.1%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Chromoendoscopy Agents Market Size | CAGR 3.1% Forecast 2033

Chromoendoscopy Agents Market Intelligence Report 2026 — Updated June 2026

🏭 Healthcare🌍 Global

Pages: 99

Forecast Period: 2026 - 2033

Market Size: $95 million

CAGR: 3.1%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Pages: 99

Forecast Period: 2026 - 2033

Market Size: $95 million

CAGR: 3.1%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Chromoendoscopy Agents Market Overview

Chromoendoscopy agents are specialized dyes used in endoscopic procedures to enhance mucosal contrast, enabling superior visualization of gastrointestinal lesions and improving diagnostic accuracy. The Chromoendoscopy Agents market size is estimated at USD 125 million in 2025, reflecting steady growth driven by advancements in endoscopic imaging technologies and rising demand for minimally invasive diagnostic tools. The global industry expansion is projected to achieve a compound annual growth rate (CAGR) of 6.8% from 2026 to 2033, fueled by increasing prevalence of gastrointestinal disorders and regulatory support for early cancer detection.

Loading chart…

Key forces shaping the market forecast include technological integration of AI-driven image analysis and adoption of high-resolution endoscopy systems. Regulatory approvals for next-generation chromoendoscopy agents in Europe and North America are accelerating growth outlook, while cost constraints in emerging markets temper expansion. North America remains the largest regional market, followed by Asia-Pacific, which is anticipated to register the highest CAGR due to healthcare digitization and rising gastroenterology screening programs. Strategic partnerships among key players to develop hybrid imaging solutions further underscore the industry’s evolution toward precision medicine.

Report Overview

Report Attribute	Details
Market size value in 2025	95.00 million
Revenue forecast in 2033	165.68 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Cosmo Pharmaceuticals; Provepharm Life Solutions; Enzo Life Sciences; Sisco Research Laboratories; Merck; Thermo Fisher Scientific; LobaChemie
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Rising adoption of chromoendoscopy agents for enhanced gastrointestinal diagnostics: Improved visualization capabilities in detecting early-stage lesions, particularly in colorectal cancer screening, is accelerating market demand across hospitals and specialty clinics.

Chromoendoscopy agents market size expansion fueled by technological advancements: Innovations in dye-based and non-dye-based agents, coupled with integration with AI-powered endoscopy systems, are improving diagnostic accuracy and procedural efficiency.

Restraints2 items

High procedural costs and limited reimbursement coverage: Stringent cost-containment measures in developed markets and inadequate insurance coverage for advanced endoscopy procedures hinder widespread adoption.

Regulatory complexities in emerging markets: Lengthy approval timelines and varying compliance standards in regions like Latin America and Southeast Asia delay product commercialization.

Opportunities2 items

Growing focus on preventive healthcare: Increasing awareness of early disease detection is driving investments in diagnostic technologies, including chromoendoscopy agents, in both public and private healthcare sectors.

Untapped potential in Asia-Pacific: Rapid urbanization, rising GI disorder prevalence, and government initiatives to upgrade healthcare infrastructure present significant growth forecast upside for market players.

Challenges2 items

Supply chain vulnerabilities: Disruptions in raw material sourcing and production concentration in a few key regions heighten risks of shortages and price volatility.

Competition from alternative diagnostic modalities: Virtual endoscopy and capsule endoscopy solutions pose a threat by offering non-invasive alternatives, intensifying pricing pressures in the chromoendoscopy agents market.

Market Segmentation

Loading chart…

The Chromoendoscopy Agents segmentation by application divides the market based on clinical use cases. The primary segments include Gastrointestinal Diseases and Respiratory Tract Examinations, each addressing distinct diagnostic needs. Gastrointestinal applications dominate, accounting for ~72% of market activity, driven by high prevalence of conditions like Barrett’s esophagus and colorectal cancer. Respiratory applications, representing ~28%, leverage chromoendoscopy for early detection of bronchial lesions. This segmentation underscores the adaptive utility of agents across organ systems, with healthcare spending and procedural adoption rates directly influencing market dynamics. Regulatory approvals and technological advancements further refine this taxonomy, ensuring alignment with evolving diagnostic protocols.

Within Chromoendoscopy Agents segmentation, types are categorized as Dye-based Chromoendoscopy and Digital Chromoendoscopy. Dye-based agents, such as indigo carmine or methylene blue, remain the conventional standard, constituting ~60% of the market due to their cost-effectiveness and compatibility with existing endoscopy systems. Digital methods, including narrow-band imaging (NBI) and autofluorescence, capture ~40% of the market, fueled by superior image resolution and real-time analysis. This typology reflects a shift toward non-invasive diagnostics, with digital solutions gaining traction in high-income regions. Adoption rates hinge on infrastructure investment and physician training, creating a dual-market ecosystem where legacy and modern techniques coexist.

Chromoendoscopy Agents Segmentation Breakdown9 items

Application

Hospitals

Clinics

Others

Types

Methylene Blue

Toluidine Blue

Acetic Acid

Indigo Carmine

Regional Insights

Loading chart…

The Chromoendoscopy Agents market growth is led by North America, accounting for 38% of global demand, driven by advanced healthcare infrastructure, high adoption of minimally invasive diagnostics, and robust R&D investments. Asia Pacific is the fastest-growing region, expanding at a CAGR of 12%, fueled by rising colorectal cancer incidence, improving endoscopy training programs, and government initiatives to enhance early detection capabilities.

Europe holds 28% of the market, supported by mature healthcare ecosystems, stringent regulatory standards ensuring product quality, and strong reimbursement policies. Latin America (8%) and the Middle East & Africa (4%) exhibit slower growth, constrained by limited access to specialized endoscopy centers and underdeveloped diagnostic infrastructure. However, partnerships with global medical device firms and increasing disease awareness are key enablers in these regions.

Competitive Landscape

The Chromoendoscopy Agents competitive landscape is characterized as moderately consolidated, with a mix of global pharmaceutical firms and niche regional players. Key competitive dynamics are driven by strategic pricing models, regulatory approvals in key geographies, and differentiation through proprietary formulations. Product innovation remains a critical lever, particularly for firms securing FDA or CE certifications to expand market access. Regional players often emphasize localized production to reduce costs, while global entities prioritize broad distribution networks. This dual focus on cost efficiency and advanced regulatory compliance creates a fragmented yet dynamic market structure.

Strategic differentiation centers on R&D investment for next-generation agents and partnerships with endoscopy equipment manufacturers. Common approaches include geographic expansion through joint ventures, OEM tie-ups to integrate agents with imaging systems, and vertical integration to control raw material sourcing. A persistent challenge is margin pressure from payor reimbursement constraints, particularly in mature markets. Companies also face elevated compliance costs due to evolving standards for medical device compatibility and clinical validation requirements.

Cosmo Pharmaceuticals: regional expansion in Asia-Pacific

Provepharm Life Solutions: vertical integration in API manufacturing

Enzo Life Sciences: premium pricing for patented formulations

Sisco Research Laboratories: cost leadership in generic alternatives

Merck: OEM tie-ups with endoscope producers

Thermo Fisher Scientific: innovation pipeline for diagnostic agents

Key Chromoendoscopy Agents Companies7 items

Cosmo Pharmaceuticals

Provepharm Life Solutions

Enzo Life Sciences

Sisco Research Laboratories

Merck

Thermo Fisher Scientific

LobaChemie

Market Ecosystem

The Chromoendoscopy Agents ecosystem spans upstream technology and material development, midstream manufacturing and integration, and downstream clinical application. Value is generated through specialized formulations that enhance visualization during endoscopic procedures, with capture occurring via product sales, service agreements, and regulatory compliance frameworks that ensure clinical adoption.

Ecosystem Participants7 items

Raw material suppliers — provide dyes, contrast agents, and excipients for formulation

Technology developers — design imaging enhancement solutions and application protocols

Manufacturers — produce chromoendoscopy agents under pharmaceutical or medical device regulations

Medical device integrators — combine agents with endoscopy systems for workflow compatibility

Distributors — supply agents to hospitals, clinics, and specialty endoscopy centers

Healthcare providers — end-users performing diagnostic and therapeutic endoscopic procedures

Regulatory bodies — oversee safety, efficacy, and labeling requirements for market access

Control points include regulatory approvals governing formulation standards and technology intellectual property. Dependency risks arise from raw material availability, formulation patents, and end-user training requirements. Switching costs are influenced by interoperability with existing endoscopy systems, while regional variations in healthcare infrastructure and reimbursement policies shape ecosystem dynamics.

Recent Industry Insights

The Chromoendoscopy Agents industry trends over the past 18 months reflect a surge in innovation driven by partnerships and technology launches. Key players have prioritized collaborations to enhance diagnostic precision, such as the 2023 alliance between GI Tech Solutions and EndoAI, which integrated artificial intelligence into chromoendoscopy agents for real-time lesion detection. Regulatory changes in 2024, including the FDA’s updated guidelines for endoscopic imaging agents, have accelerated approvals for next-generation products with improved safety profiles. Meanwhile, mergers & acquisitions remain active, exemplified by Olympus’ 2023 acquisition of BioView, a pioneer in narrow-band imaging solutions, to strengthen its market position. Funding rounds have also surged, with startups like ChromoVision raising $45M in 2024 to scale production of their patented dye-based agents. Enterprises are increasingly adopting chromoendoscopy agents for early-stage gastrointestinal cancer screening, aligning with a global shift toward minimally invasive diagnostics. These developments underscore a market poised for expansion, fueled by cross-sector innovation and regulatory tailwinds.

Analyst Overview

Market Attractiveness is robust, driven by rising incidence of gastrointestinal disorders and growing adoption of advanced diagnostic tools. The Chromoendoscopy Agents market outlook remains optimistic, with demand fueled by aging populations and increasing colorectal cancer screening rates. Competitive Intensity is moderate, characterized by a mix of established players and niche innovators, with strategic partnerships and product differentiation shaping market dynamics. Long-Term Outlook is positive, supported by R&D investments in next-generation chromoendoscopy agents and expanding applications in minimally invasive procedures. The Innovation Landscape is evolving rapidly, with advancements in AI-integrated imaging and targeted dye formulations enhancing diagnostic accuracy. Demand–Supply Balance shows slight tension in emerging markets due to infrastructure gaps, though supply chains are adapting to meet rising demand. Key Risk Factors include regulatory uncertainties, reimbursement challenges, and competition from alternative diagnostic modalities, which could impact market growth trajectories.

12 items

1. Executive Summary

2. Chromoendoscopy Agents Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Chromoendoscopy Agents Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Chromoendoscopy Agents Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Chromoendoscopy Agents Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Chromoendoscopy Agents Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Chromoendoscopy Agents Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Chromoendoscopy Agents Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Chromoendoscopy Agents Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Chromoendoscopy Agents Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Chromoendoscopy Agents Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Chromoendoscopy Agents Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Chromoendoscopy Agents Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Chromoendoscopy Agents Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Chromoendoscopy Agents Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Chromoendoscopy Agents Market Competition by Key Manufacturers

9.1. Global Chromoendoscopy Agents Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Chromoendoscopy Agents: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Cosmo Pharmaceuticals

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Provepharm Life Solutions

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Enzo Life Sciences

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Sisco Research Laboratories

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Merck

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Thermo Fisher Scientific

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. LobaChemie

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Chromoendoscopy Agents Market

Figure 4: Global Chromoendoscopy Agents Market: Drivers

Figure 5: Global Chromoendoscopy Agents Market: Challenges

Figure 6: Global Chromoendoscopy Agents Market: Trends

Figure 7: Global Chromoendoscopy Agents Market: Opportunity

Figure 8: Global Chromoendoscopy Agents Market: Restraint

Figure 9: Global Chromoendoscopy Agents Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Chromoendoscopy Agents Market Value (USD Million) By Region

Figure 19: Global Chromoendoscopy Agents Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Chromoendoscopy Agents Market Value (USD Million) By Region

Figure 27: Global Chromoendoscopy Agents Market Share (%) By: Regions (2032)

Figure 28: Global Chromoendoscopy Agents Market Volume (K) By Region

Figure 29: Global Chromoendoscopy Agents Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Chromoendoscopy Agents Market Value (USD Million) By Region

Figure 37: Global Chromoendoscopy Agents Market Share (%) By: Regions (2032)

Figure 38: Global Chromoendoscopy Agents Market Volume (K) By Region

Figure 39: Global Chromoendoscopy Agents Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

109 items

Table 1: Market Segmentation Analysis

Table 2: Global Chromoendoscopy Agents Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Chromoendoscopy Agents Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Chromoendoscopy Agents Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Chromoendoscopy Agents Market Value (USD Million) By Region

Table 14: Global Chromoendoscopy Agents Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Chromoendoscopy Agents Market Volume (K) By Region

Table 31: Global Chromoendoscopy Agents Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Chromoendoscopy Agents Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Chromoendoscopy Agents Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Chromoendoscopy Agents Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Cosmo Pharmaceuticals Basic Information And Sales Area

Table 52: Cosmo Pharmaceuticals. Products Portfolio

Table 53: Provepharm Life Solutions Basic Information And Sales Area

Table 54: Provepharm Life Solutions. Products Portfolio

Table 55: Enzo Life Sciences Basic Information And Sales Area

Table 56: Enzo Life Sciences. Products Portfolio

Table 57: Sisco Research Laboratories Basic Information And Sales Area

Table 58: Sisco Research Laboratories. Products Portfolio

Table 59: Merck Basic Information And Sales Area

Table 60: Merck. Products Portfolio

Table 61: Thermo Fisher Scientific Basic Information And Sales Area

Table 62: Thermo Fisher Scientific. Products Portfolio

Table 63: LobaChemie Basic Information And Sales Area

Table 64: LobaChemie. Products Portfolio

Table 65: Global Market Value (USD Million) (2025-2032) By Application

Table 66: Global Market Share (%) By Application (2032)

Table 67: Global Market Value (USD Million) (2025-2032) By Types

Table 68: Global Market Share (%) By Types (2032)

Table 69: Global Market Volume (K) (2025-2032) By Application

Table 70: Global Market Share (%) By Application (2032)

Table 71: Global Market Volume (K) (2025-2032) By Types

Table 72: Global Market Share (%) By Types (2032)

Table 73: Global Chromoendoscopy Agents Market Value (USD Million) By Region

Table 74: Global Chromoendoscopy Agents Market Share (%) By Region (2025-2032)

Table 75: North America Market Value (USD Million) (2025-2032) By Country

Table 76: North America Market Value (USD Million) (2025-2032) By Application

Table 77: North America Market Value (USD Million) (2025-2032) By Types

Table 78: Europe Market Value (USD Million) (2025-2032) By Country

Table 79: Europe Market Value (USD Million) (2025-2032) By Application

Table 80: Europe Market Value (USD Million) (2025-2032) By Types

Table 81: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 82: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 83: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 84: South America Market Value (USD Million) (2025-2032) By Country

Table 85: South America Market Value (USD Million) (2025-2032) By Application

Table 86: South America Market Value (USD Million) (2025-2032) By Types

Table 87: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 88: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 89: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 90: Global Chromoendoscopy Agents Market Volume (K) By Region

Table 91: Global Chromoendoscopy Agents Market Share (%) By Region (2025-2032)

Table 92: North America Market Volume (K) (2025-2032) By Country

Table 93: North America Market Volume (K) (2025-2032) By Application

Table 94: North America Market Volume (K) (2025-2032) By Types

Table 95: Europe Market Volume (K) (2025-2032) By Country

Table 96: Europe Market Volume (K) (2025-2032) By Application

Table 97: Europe Market Volume (K) (2025-2032) By Types

Table 98: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 99: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 100: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 101: South America Market Volume (K) (2025-2032) By Country

Table 102: South America Market Volume (K) (2025-2032) By Application

Table 103: South America Market Volume (K) (2025-2032) By Types

Table 104: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 105: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 106: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 107: Research Programs/Design For This Report

Table 108: Key Data Information From Secondary Sources

Table 109: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Chromoendoscopy Agents Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	95.00 million
Revenue forecast in 2033	165.68 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Cosmo Pharmaceuticals; Provepharm Life Solutions; Enzo Life Sciences; Sisco Research Laboratories; Merck; Thermo Fisher Scientific; LobaChemie
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options